Skip to content

Research at St Andrews

Green fluorescent protein as a reporter of prion protein folding

Research output: Contribution to journalArticle



S Vasiljevic, J Ren, Y Yao, K Dalton, Catherine Sarah Adamson, I.M. Jones

School/Research organisations


Background The amino terminal half of the cellular prion protein PrPc is implicated in both the binding of copper ions and the conformational changes that lead to disease but has no defined structure. However, as some structure is likely to exist we have investigated the use of an established protein refolding technology, fusion to green fluorescence protein (GFP), as a method to examine the refolding of the amino terminal domain of mouse prion protein. Results Fusion proteins of PrPc and GFP were expressed at high level in E.coli and could be purified to near homogeneity as insoluble inclusion bodies. Following denaturation, proteins were diluted into a refolding buffer whereupon GFP fluorescence recovered with time. Using several truncations of PrPc the rate of refolding was shown to depend on the prion sequence expressed. In a variation of the format, direct observation in E.coli, mutations introduced randomly in the PrPc protein sequence that affected folding could be selected directly by recovery of GFP fluorescence. Conclusion Use of GFP as a measure of refolding of PrPc fusion proteins in vitro and in vivo proved informative. Refolding in vitro suggested a local structure within the amino terminal domain while direct selection via fluorescence showed that as little as one amino acid change could significantly alter folding. These assay formats, not previously used to study PrP folding, may be generally useful for investigating PrPc structure and PrPc-ligand interaction.


Original languageEnglish
Pages (from-to)59
Number of pages9
JournalVirology Journal
Publication statusPublished - Aug 2006

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Modular cell-based platform for high throughput identification of compounds that inhibit a viral interferon antagonist of choice

    Vasou, A., Paulus, C., Narloch, J., Gage, Z. O., Rameix-Welti, M-A., Eléouët, J-F., Nevels, M., Randall, R. E. & Adamson, C. S., Feb 2018, In : Antiviral Research. 150, p. 79-92

    Research output: Contribution to journalArticle

  2. Structure-activity relationships of the Human Immunodeficiency Virus Type 1 maturation inhibitor PF-46396

    Murgatroyd, C., Pirrie, L., Fanny Tran, Smith, T. K., Westwood, N. J. & Adamson, C. S., Sep 2016, In : Journal of Virology. 90, 18, p. 8181-8197 17 p.

    Research output: Contribution to journalArticle

  3. Derivatisable cyanobactin analogues: a semisynthetic approach

    Oueis, E., Adamson, C. S., Mann, G., Ludewig, H., Naismith, J., Redpath, P., Migaud, M., Westwood, N. J. & Naismith, J., 14 Dec 2015, In : ChemBioChem. 16, 18, p. 2646-2650

    Research output: Contribution to journalArticle

  4. Inhibitors of the interferon response enhance virus replication in vitro.

    Stewart, C. E., Randall, R. E. & Adamson, C. S., 12 Nov 2014, In : PLoS One. 9, 11, 8 p., e112014.

    Research output: Contribution to journalArticle

Related by journal

  1. Unexpected complexity in the interference activity of a cloned influenza defective interfering RNA

    Meng, B., Bentley, K., Marriott, A. C., Scott, P. D., Dimmock, N. J. & Easton, A. J., 24 Jul 2017, In : Virology Journal. 14, 1, 16 p., 138.

    Research output: Contribution to journalArticle

ID: 483680